CLINICAL_TRIALS
trial_result
· 2017-06-02
Clinical Trial Update: Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial comparing fixed-ratio insulin degludec/liraglutide versus insulin degludec alone and liraglutide alone in adults with type 2 diabetes; results com…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2017-06-02